Related Experiment Video

Updated: Jul 20, 2025

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

48.3K

Ketamine Infusions for Treatment-Resistant Neuropathic Pruritus

Shawn G Kwatra1, Anusha Kambala1, Hannah Cornman1

  • 1Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

JAMA Dermatology
|August 2, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

12.2K
Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
06:04

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

8.2K

Related Experiment Videos

Last Updated: Jul 20, 2025

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

48.3K
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

12.2K
Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
06:04

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

8.2K

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

199
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
199
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

155
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
155

Articles linked to this work by shared authors, journal, and citation graph.

The evolving understanding of prurigo nodularis.

Clinical and experimental dermatology·2026

Systemic Glucocorticoid Immunosuppression and Survival Among Immune Checkpoint Inhibitor Recipients.

JAMA network open·2026

Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.

Dermatology and therapy·2026

Somatic mutations reveal hyperactive Notch signaling in prurigo nodularis.

JCI insight·2026

Targeting noncanonical TGF-beta signaling: inhibition effects on the human keloid fibroblast transcriptome.

Itch (Philadelphia, Pa.)·2026

Dupilumab subgroup responder analysis: a post hoc analysis from LIBERTY PRIME and PRIME2 in prurigo nodularis.

The Journal of dermatological treatment·2026

AI-Assisted Line-Field Confocal Optical Coherence Tomography to Detect Subclinical Basal Cell Carcinoma.

JAMA dermatology·2026

Cherry Angiomas in Individuals With Neurofibromatosis Type 1.

JAMA dermatology·2026

Risk Stratification Models for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant.

JAMA dermatology·2026

Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.

JAMA dermatology·2026

Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa.

JAMA dermatology·2026

Pyoderma Gangrenosum Phenotype Classification.

JAMA dermatology·2026

Invasive vs Non-invasive Management of Elderly Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI).

Irish medical journal·2026

Nicotinamide Mononucleotide Attenuates Inflammatory Activation, Choroidal Neovascularization, and Lesion-Associated Remodeling.

Investigative ophthalmology & visual science·2026

Stenosis of the glomerulotubular neck with chronic kidney disease.

Journal of nephrology·2026

Safinamide dual molecular mechanisms: sodium channel and glutamate modulation as a translational rationale for neuropathic pain - A narrative review.

Drug metabolism and personalized therapy·2026

Modest Reduction in CAG Repeat Length Rescues Motor Deficits but Not Purkinje Cell Pathology and Gliosis in Spinocerebellar Ataxia Type 1 Mice.

Neuroglia (Basel, Switzerland)·2026

Effects of Naringenin on Diabetic Nephropathy: A Systematic Review and Meta-Analysis of Rodent Studies.

Food science & nutrition·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us